These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34783094)

  • 1. Choosing clinically interpretable summary measures and robust analytic procedures for quantifying the treatment difference in comparative clinical studies.
    McCaw ZR; Tian L; Wei J; Claggett BL; Bretz F; Fitzmaurice G; Wei LJ
    Stat Med; 2021 Dec; 40(28):6235-6242. PubMed ID: 34783094
    [No Abstract]   [Full Text] [Related]  

  • 2. [GRADE guidelines: 13. Preparing Summary of Findings tables and evidence profiles - continuous outcomes].
    Schell LK; Meerpohl JJ; Gartlehner G; Langer G; Perleth M; Schünemann HJ
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(5-6):333-47. PubMed ID: 25066353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical Recommendations on Quantifying and Interpreting Treatment Effects in the Presence of Terminal Competing Risks: A Review.
    McCaw ZR; Claggett BL; Tian L; Solomon SD; Berwanger O; Pfeffer MA; Wei LJ
    JAMA Cardiol; 2022 Apr; 7(4):450-456. PubMed ID: 34851356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying Treatment Effects in Trials with Multiple Event-Time Outcomes.
    Claggett BL; McCaw ZR; Tian L; McMurray JJV; Jhund PS; Uno H; Pfeffer MA; Solomon SD; Wei LJ
    NEJM Evid; 2022 Oct; 1(10):. PubMed ID: 37645407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytic and Data Sharing Options in Real-World Multidatabase Studies of Comparative Effectiveness and Safety of Medical Products.
    Toh S
    Clin Pharmacol Ther; 2020 Apr; 107(4):834-842. PubMed ID: 31869442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creation of Interpretable Summary Measures in Displaying Results from Mixed-effects Logit Models.
    Liu X; Belsher BE; Evatt DP
    J Biom Biostat; 2016 Jun; 7(3):. PubMed ID: 27500009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical study.
    Zhao L; Tian L; Uno H; Solomon SD; Pfeffer MA; Schindler JS; Wei LJ
    Clin Trials; 2012 Oct; 9(5):570-7. PubMed ID: 22914867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decision-analytic modeling to evaluate benefits and harms of medical tests: uses and limitations.
    Trikalinos TA; Siebert U; Lau J
    Med Decis Making; 2009; 29(5):E22-9. PubMed ID: 19734441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes.
    Guyatt GH; Thorlund K; Oxman AD; Walter SD; Patrick D; Furukawa TA; Johnston BC; Karanicolas P; Akl EA; Vist G; Kunz R; Brozek J; Kupper LL; Martin SL; Meerpohl JJ; Alonso-Coello P; Christensen R; Schunemann HJ
    J Clin Epidemiol; 2013 Feb; 66(2):173-83. PubMed ID: 23116689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Response Data for Assessing Treatment Effects in Comparative Clinical Studies.
    Huang B; Tian L; McCaw ZR; Luo X; Talukder E; Rothenberg M; Xie W; Choueiri TK; Kim DH; Wei LJ
    Ann Intern Med; 2020 Sep; 173(5):368-374. PubMed ID: 32628533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analytic approaches and effect sizes to account for 'nuisance heterogeneity' in comparative physiology.
    Noble DWA; Pottier P; Lagisz M; Burke S; Drobniak SM; O'Dea RE; Nakagawa S
    J Exp Biol; 2022 Mar; 225(Suppl_1):. PubMed ID: 35258606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to Quantify and Interpret Treatment Effects in Comparative Clinical Studies of COVID-19.
    McCaw ZR; Tian L; Vassy JL; Ritchie CS; Lee CC; Kim DH; Wei LJ
    Ann Intern Med; 2020 Oct; 173(8):632-637. PubMed ID: 32634024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A framework for quantifying net benefits of alternative prognostic models.
    Rapsomaniki E; White IR; Wood AM; Thompson SG;
    Stat Med; 2012 Jan; 31(2):114-30. PubMed ID: 21905066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choosing and evaluating clinical performance measures.
    McGlynn EA
    Jt Comm J Qual Improv; 1998 Sep; 24(9):470-9. PubMed ID: 9770637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing Clinical Equivalence in Oncology Biosimilar Trials With Time-to-Event Outcomes.
    Uno H; Schrag D; Kim DH; Tang D; Tian L; Rugo HS; Wei LJ
    JNCI Cancer Spectr; 2019 Dec; 3(4):pkz058. PubMed ID: 32337484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the quality of the implemented meta-analytic procedures in chronic pain treatment meta-analyses?
    Fishbain D; Cutler RB; Rosomoff HL; Rosomoff RS
    Clin J Pain; 2000 Mar; 16(1):73-85. PubMed ID: 10741821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Biomedical Longitudinal Multisensor Data: Extracting Interpretable Features by Context
    Schreiber M; Handel T; Ivanova G
    Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():580-583. PubMed ID: 31945965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Minimally Invasive Surgery Provide Better Clinical or Radiographic Outcomes Than Open Surgery in the Treatment of Hallux Valgus Deformity? A Systematic Review and Meta-analysis.
    Alimy AR; Polzer H; Ocokoljic A; Ray R; Lewis TL; Rolvien T; Waizy H
    Clin Orthop Relat Res; 2023 Jun; 481(6):1143-1155. PubMed ID: 36332131
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.